[ad_1]
Torrent Pharmaceuticals Limited has once again extended its blood pressure medication recall because tablets contain small amounts of a carcinogen.
In a statement dated September 19, the Food and Drug Administration (FDA) announced that Torrent Pharmaceuticals Limited had voluntarily extended the recall to other batches of its Losartan potassium tablets USP and potassium / hydrochlorothiazide tablets. Losartan, used for the treatment of hypertension. Left ventricular hypertrophy and nephropathy in patients with type 2 diabetes.
REMINDER OF DRUGS AGAINST BLOOD PRESSURE ON A POSSIBLE INGREDIENT CAUSING CANCER
Specifically, the expanded recall includes "3 additional lots of losartan potassium USP tablets and 2 lots of Losartan potassium / hydrochlorothiazide tablets, USP," the FDA said in a statement.
One of the affected tablets.
(FDA)
The ingredient detected in tablets has been identified as N-methylnitrosobutyric acid (NMBA), an animal known and potentially carcinogenic to humans. The company said the recall was only for products with more FDA authorized NMBA than allowed.
"Patients taking Losartan Potassium Tablets, USP and Losartan Potassium / Hydrochlorothiazide Tablets, USP should continue taking their medications because the risk of harm to the patient's health may be greater if treatment is stopped immediately without alternative treatment," the FDA advises patients to contact their pharmacist or doctor about an alternative medicine.
The brand marks the fifth time that the company expands the recall. The fourth was announced in April.
CLICK HERE TO GET THE FOX NEWS APP
To learn more about the recently recalled lots, read the announcement of the pharmaceutical company at FDA.gov.
Fox News' Alexandria Hein contributed to this report.
[ad_2]
Source link